Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial

Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial

Abstract We previously demonstrated the safety and feasibility of mesenchymal stem cell (MSC) transplantation for bronchopulmonary dysplasia (BPD) in preterm infants in a phase I clinical trial. We thus investigated the therapeutic efficacy of MSCs for BPD in premature infants. A phase II double‐bli...

Full description

Bibliographic Details
Main Authors: So Yoon Ahn, Yun Sil Chang, Myung Hee Lee, Se In Sung, Byong Sop Lee, Ki Soo Kim, Ai‐Rhan Kim, Won Soon Park
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Stem Cells Translational Medicine
Subjects:
bronchopulmonary dysplasia
cell transplantation
mesenchymal stem cells
premature infants
Online Access:https://doi.org/10.1002/sctm.20-0330

Internet

https://doi.org/10.1002/sctm.20-0330

Similar Items